Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Agnes Benedict"'
Autor:
Po‐Jung Su, Ying Xiao, Amy Y. Lin, Connie Goh, Ethan Wu, Kevin Liu, Patrick Chou, Kaitlin Kuo, Roberto Palencia, Jane Chang, Mairead Kearney, Venediktos Kapetanakis, Agnes Benedict
Publikováno v:
Cancer Reports, Vol 6, Iss 10, Pp n/a-n/a (2023)
Abstract Background Patients with locally advanced or metastatic urothelial carcinoma have limited treatment options and a poor prognosis. The JAVELIN Bladder 100 trial showed that avelumab as first‐line maintenance plus best supportive care signif
Externí odkaz:
https://doaj.org/article/2042b9fe238f47b3a68141f7b30dd0fb
Publikováno v:
HemaSphere, Vol 7, p e397050f (2023)
Externí odkaz:
https://doaj.org/article/04c0943c73c642dc84c756f7fb9c0704
Autor:
Irina Proskorovsky, Agnes Benedict, Sylvie Negrier, Danielle Bargo, Rickard Sandin, Krishnan Ramaswamy, Jigar Desai, Joseph C. Cappelleri, James Larkin
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background In the absence of head-to-head trials comparing axitinib with cabozantinib or everolimus, the aim of this study was to conduct an indirect comparison of their relative efficacy in patients with metastatic renal cell carcinoma (mRC
Externí odkaz:
https://doaj.org/article/3fa403c1198d4ea3bd84bcca33a779db
Autor:
David McDermott, Michael Atkins, Ahmad Tarhini, Apoorva Ambavane, Agnes Benedict, Cho-Han Lee, Corey Ritchings, Brian Stwalley, Meredith Regan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/e6af1d2b1dce4589af52cd09b5d7a922
Autor:
Alfredo Carrato, Lucjan Wyrwicz, Agnes Benedict, Josep M Borras, Eloy Espin-Basany, Zorana Maravic, Iga Rawicka, Anna Horvath, Vassiliki Fotaki, Ana Ruiz-Casado, Agota Petrányi, Liesbeth Lemmens, Jadranka Stanisic Trenevski
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background Despite being highly preventable and treatable if diagnosed early, colorectal cancer (CRC) remains the second leading cause of cancer-related death in Europe. Limited information is available from the patient perspective on the persisting
Externí odkaz:
https://doaj.org/article/0e7e32826f8b4c7ca41c44971dad548a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valerie Aponte-Ribero, Agnes Benedict, Apoorva Ambavane, David F. McDermott, Sumati Rao, Ahmad A. Tarhini, Meredith M. Regan, Corey Ritchings, Michael B. Atkins, Komal Gupte-Singh
Publikováno v:
Immunotherapy. 11:283-295
Aim: The cost–effectiveness of treatment sequences in BRAF-mutant advanced melanoma. Materials & methods: A discrete event simulation model was developed to estimate total costs and health outcomes over a patient's lifetime (30 years). Efficacy was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17947ee449b31d337aaabbf475c25534
https://doi.org/10.2217/imt-2018-0168
https://doi.org/10.2217/imt-2018-0168
Autor:
Ahmad A. Tarhini, Corey Ritchings, Apoorva Ambavane, Michael B. Atkins, Cho-Han Lee, Meredith M. Regan, David F. McDermott, Brian Stwalley, Agnes Benedict
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Patients with BRAF mutant advanced melanoma can be treated sequentially with immunotherapies (IO) and BRAF+MEK inhibitors. We evaluated the clinical outcomes associated with various treatment sequences for BRAF mutant advanced melanoma bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d6de41767bffa21b1aca4982ae91421
https://doi.org/10.1136/jitc-2020-sitc2020.0219
https://doi.org/10.1136/jitc-2020-sitc2020.0219
Autor:
Agnes Benedict, Lucjan Wyrwicz, Josep M. Borràs, Z. Maravic, Eloy Espin-Basany, Jadranka Stanisic Trenevski, Agota Petrányi, Alfredo Carrato, Anna Horváth, Liesbeth Lemmens, Ana Ruiz-Casado, Vassiliki Fotaki, Iga Rawicka
Publikováno v:
ESMO Open
Dipòsit Digital de la UB
Universidad de Barcelona
ESMO Open, Vol 5, Iss 5 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
ESMO Open, Vol 5, Iss 5 (2020)
Background Despite being highly preventable and treatable if diagnosed early, colorectal cancer (CRC) remains the second leading cause of cancer-related death in Europe. Limited information is available from the patient perspective on the persisting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9e5630369934f7fb59a9ae5d944c9d2
https://pubmed.ncbi.nlm.nih.gov/32998966
https://pubmed.ncbi.nlm.nih.gov/32998966
To identify the pattern of the risk of death over long-term in unresectable hepatocellular carcinoma by determining the appropriate distribution to extrapolate overall survival and to assess the role of the Weibull distribution as the standard surviv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1a2ca7c63ef42b9e6bb79eb69f466f8
